NMS Labs Release: New Synthetic Drugs Circumvent DEA Scheduled Chemicals Found in Synthetic Cannabinoids

WILLOW GROVE, Pa.--(BUSINESS WIRE)--There is no sign of a slowdown in the appearance of new drugs in the illicit designer drug pipeline, according to data just released from NMS Labs, the nation’s leader in designer drug testing innovation. Among synthetic cannabinoids, the latest trends point toward an increase in the use of drugs not explicitly covered under the latest Federal drug laws (JWH-210, JWH-122, and AM-2201).

Back to news